US 11261444
Organic compositions to treat EPAS1-related diseases
granted A61KA61K31/7105A61K31/7115
Quick answer
US patent 11261444 (Organic compositions to treat EPAS1-related diseases) held by Arrowhead Pharmaceuticals, Inc. expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/7105, A61K31/7115, A61K31/712, A61K31/7125